The western North Carolina plant that makes 60 percent of the country's intravenous fluid supply has restarted its highest-producing manufacturing line after being ravaged by flooding brought by Hurricane Helene last month.

While it's an encouraging sign of recovery as hospitals nationwide struggle with shortages of fluids, supply is still likely to remain tight for the coming weeks.

IV fluid-maker Baxter Inc, which runs the Marion plant inundated by Helene, said Thursday that the restarted production line could produce, at peak, 25 percent of the plant's total production and about 50 percent of the plant's production of one-liter IV solutions, the product most commonly used by hospitals and clinics.

Read full article

Comments

More than 86 percent of healthcare providers surveyed across the US are experiencing shortages of intravenous fluids after Hurricane Helene's rampage took out a manufacturing plant in western North Carolina that makes 60 percent of the country's supply.

IV fluids are used for everything from intravenous rehydration to drug delivery. The plant also made peritoneal dialysis fluids used to treat kidney failure.

Premier, a group purchasing organization for medical supplies that counts thousands of hospitals and health systems among its members, surveyed 257 such providers earlier this week. The poll makes clear that supplies are unsurprisingly imperiled.

Read full article

Comments

Hurricane Helene's catastrophic damage and flooding to the Southeastern states may affect the country's medical supply chain.

Hospitals nationwide are bracing for a possible shortage of essential intravenous fluids after the cataclysmic storm inundated a vital manufacturing plant in North Carolina.

The plant is Baxter International's North Cove manufacturing facility in Marion, which is about 35 miles northeast of Asheville. Helene unleashed unprecedented amounts of rain throughout the western part of the state, killing dozens and ravaging numerous communities, homes, and other structures, including the plant.

Read full article

Comments